🔗 Share this article

Treasury head Reeves has revealed she is preparing "focused measures to deal with cost of living issues" in next month's Budget.

In comments to media outlets, she stated that reducing price rises is a collective duty of both the administration and the Bank of England.

The UK's inflation rate is projected to be the highest among the Group of Seven industrialized countries this calendar year and next.

Possible Energy Bill Measures

Sources suggest the administration could intervene to bring down energy bills, such as by slashing the present 5% rate of VAT applied on energy.

A further approach is to reduce some of the policy costs presently included in household expenses.

Fiscal Constraints and Analyst Expectations

The government will receive the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will show how much scope there is for these actions.

The consensus from the majority of economists is that Reeves will have to declare higher taxes or expenditure reductions in order to adhere to her declared fiscal targets.

Previously on the same day, estimates showed there was a £22bn gap for the chancellor to resolve, which is at the lower end of expectations.

"There's a collective responsibility between the Bank of England and the administration to continue tackling some of the drivers of price increases," Reeves told the BBC in Washington, at the yearly gatherings of the International Monetary Fund and global financial institution.

Revenue Pledges and International Issues

While much of the attention has been on probable tax increases, the chancellor said the most recent information from the OBR had not changed her pledge to campaign commitments not to increase rates on income tax, VAT or National Insurance.

She attributed an "uncertain global environment" with increasing geopolitical and trade concerns for the fiscal revenue measures, likely to be targeted on those "most able to pay."

International Economic Disputes

Referring to worries about the United Kingdom's commercial links with China she said: "Our security interests invariably come first."

Last week's declaration by Chinese authorities to increase export controls on rare earths and other materials that are essential for high-technology production led US President Donald Trump to propose an additional 100% import tax on imports from China, raising the risk of an all-out trade war between the two global powers.

The US Treasury Secretary called the Chinese action "commercial pressure" and "a global supply chain control attempt."

Inquired about accepting the American proposal to join its dispute with China, the Chancellor said she was "very concerned" by Chinese actions and urged the Chinese government "not to put up barriers and limit trade."

She said the move was "bad for the global economy and generates further obstacles."

"In my view there are areas where we should address China, but there are also significant chances to sell into Chinese markets, including financial services and other sectors of the economic system. We've got to achieve that equilibrium appropriate."

The Treasury chief also affirmed she was cooperating with G7 counterparts "regarding our own critical minerals plan, so that we are less reliant."

Health Service Medicine Costs and Investment

Reeves also acknowledged that the price the NHS spends on drugs could increase as a result of ongoing discussions with the Trump administration and its drugs companies, in return for reduced taxes and investment.

A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or abandoning investments in the UK, with several attributing the low prices they are getting.

Recently, the government science advisor said the price the health service pays for medicines would must go up to prevent businesses and drug research funding departing from the UK.

Reeves told the BBC: "We have seen as a result of the pricing regime, that medical research, recent pharmaceuticals have not been provided in the United Kingdom in the extent that they are in other European countries."

"We want to guarantee that individuals receiving treatment from the National Health Service are can access the top critical treatments in the world. And so we are looking at these issues, and... aiming to secure additional investment into Britain."